## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-05-20T01:19:09.062Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "UpToDate Lexidrug" developer_entity: "Lexi-Comp" bundle_id: "com.lexi.Individual" app_store_id: "313401238" google_play_id: "com.lexi.android" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: true market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-05-11" report_date: "2026-05-20" last_verified: "2026-05-20" report_version: "9.4.2" total_reviews: 7602 overall_rating: 4.19 sentiment: "Frustrated" sentiment_score: 25 confidence: "high" confidence_score: 0.9 top_praise_theme: "Reliable clinical reference content remains a daily essential for medical professionals in clinical settings" top_complaint_theme: "Persistent database download failures prevent access to critical drug interactions and compatibility information" top_request_theme: "Restoration of direct home screen access to the primary drug library database" review_sample_size: 106 total_review_count: 106 analyzed_review_count: 66 data_age_days: 0 momentum_velocity: "maintenance" intelligence_version: 3 nemesis: "Drugs.com Medication Guide" competitor_count: 8 tags: ["medical", "subscription", "frustrated sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals", "including"] canonical_url: "https://marlvel.ai/intel-report/medical/com-lexi-individual" license: "CC-BY-NC 4.0" content_version: "v2" --- # UpToDate Lexidrug App Audit ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.19 · Sentiment Frustrated - **Recent focus**: Persistent database download failures prevent access to critical drug interactions and compatibility information (top complaint) · Reliable clinical reference content remains a daily essential for medical professionals in clinical settings (top praise) · Restoration of direct home screen access to the primary drug library database (top request) > **TL;DR:** UpToDate Lexidrug is a medical app by Lexi-Comp, rated 4.19/5 by 7.6K users, with Frustrated user sentiment (25/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** UpToDate Lexidrug faces Frustrated user sentiment (4.19/5 from 7.6K reviews), with persistent database download failures prevent access to critical drug interactions and compatibility information as the primary user concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.19/5 (7.6K reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | Lexi-Comp | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | High (0.9/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Lexi-Comp - **Category:** Medical - **Target Audience:** Healthcare professionals including pharmacists, physicians, nurses, and students requiring evidence-based drug information. - **Platforms:** iOS & Android - **Version Audited:** 9.4.2 - **Audit Date:** 2026-05-20 - **Signal Count:** 106 reviews analyzed - **Confidence:** High (0.9/1.0) - **App Store ID (iOS):** 313401238 - **Bundle ID:** com.lexi.Individual - **Google Play ID:** com.lexi.android - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-05-20 - **Short Description:** UpToDate Lexidrug (formerly Lexicomp), drug monographs, interactions & more ## Executive Snapshot **What it is:** UpToDate Lexidrug is a professional-grade drug reference app providing clinical monographs, interaction checkers, and medical calculators for healthcare providers. **Why users hire it:** Clinicians hire this tool for evidence-based, offline-accessible drug information that ensures patient safety during point-of-care decisions. ## App DNA (Features & Intent) - **[Standard] Drug Interaction Checker:** Interactive tool to identify potential adverse reactions between multiple medications - **[Differentiator] Offline Database Access:** Ability to store drug monographs and clinical content locally on the device * *User Intent:* Users want uninterrupted access without internet dependency. - **[Standard] Medical Calculators:** Integrated suite of hundreds of clinical calculators for dosing and therapeutic support - **[Differentiator] Multidisciplinary Editorial Updates:** Clinical information reviewed and updated daily by an internal editorial team * *User Intent:* Users are motivated by consistent progression and daily incentives. ## Market Position {#market-position} UpToDate Lexidrug holds a #17 Grossing position in the US Medical category, reflecting strong professional monetisation despite a high-friction UI. The gap between its high-value clinical content and the recent technical instability creates a vulnerability to niche competitors. ## Monetization Strategy - **Model:** Subscription - **Tiers:** 14-day free trial, $29.99/month - **Analysis:** Subscription model anchored at $29.99/month, targeting professional users with a 14-day trial conversion funnel. ## 🔴 User Sentiment (High Confidence: 66 of 106 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.19/5 - **Platform Split:** iOS 4.7/5 (3.7K ratings) | Android 3.7/5 (3.9K ratings) - **Overall Sentiment:** Frustrated - **Note:** The 4.19/5 store rating reflects cumulative history, while the Frustrated sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Praises - **Reliable clinical reference content remains a daily essential for medical professionals in clinical settings** ### Top Complaints (Impact Areas) - **Persistent database download failures prevent access to critical drug interactions and compatibility information** - **UI navigation changes hide essential drug library tools behind excessive menu clicks post-update** - **Authentication and update loops lock users out of paid content despite active subscriptions** ### Top Requests (What Users Want) - **Restoration of direct home screen access to the primary drug library database** ## SWOT Analysis {#swot} **Core Strengths:** - Daily editorial updates establish clinical authority - Offline database access creates high switching costs **Critical Frictions:** - Persistent database download failures - UI navigation regressions hiding core tools - Authentication loops locking out paid subscribers **Growth Levers:** - Expand B2B institutional partnerships - Integrate calculators into monograph view **Market Threats:** - Drugs.com high-velocity release cadence - Professional migration to stable niche tools ## Recent Changes (v2 → v3) {#recent-changes} The app's competitive position is weakening due to technical instability and UI navigation regressions that hinder professional workflows. **Overall trend**: Declining **Compared at**: 2026-05-20 ### High-impact changes - **[Declined] Rating and Sentiment Score Drop** (sentiment) — Rating decreased from 4.71 to 4.2, and the sentiment score dropped from 32 to 25. - **[Added] New Critical Complaints** (sentiment) — Users report authentication loops and update prompts locking them out of paid content, alongside UI navigation friction from menu changes. ### Medium-impact changes - **[Shifted] Feature Competitive Positioning** (features) — Drug Interaction Checker moved from differentiator to standard; Offline Database Access moved from standard to differentiator. - **[Added] New Competitive Threats** (swot) — Added threats regarding competitor release velocity and professional migration to stable alternatives. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### UpToDate Lexidrug vs Drugs.com Medication Guide — Head to Head - **[Drugs.com Medication Guide](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide)** by Drugs.com: With over 36,000 reviews and a high-velocity release cadence, this app dominates the general-purpose drug reference market. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Offers a massive, free-to-access consumer-facing database that captures broader search intent than professional-only tools. - Maintains a high release frequency of 6 updates in six months, ensuring rapid adaptation to platform changes. - Provides a comprehensive pill identification tool integrated directly into the core medication guide experience. - **Where UpToDate Lexidrug wins:** - ✅ Delivers specialized clinical-grade monographs and therapeutic decision support tools tailored specifically for healthcare professionals. - ✅ Maintains a more rigorous editorial standard for multidisciplinary clinical evidence compared to general consumer references. - **Where Drugs.com Medication Guide wins:** - ❌ Leverages a massive user base to drive higher engagement and broader visibility in general app store searches. - ❌ Provides a more accessible, user-friendly interface that caters to both patients and busy clinicians needing quick answers. - **Verdict:** The target app must emphasize its clinical depth and professional-grade decision support to differentiate from the broader, high-volume reach of Drugs.com. ### Contenders (Strong Challengers) - **[Sanford Guide Antimicrobial](https://marlvel.ai/intel-report/medical/com-sanfordguide-amt)** by Antimicrobial Therapy, Inc. [Moat: Medium]: Highly specialized niche leader with strong professional loyalty and consistent update velocity. - Focuses exclusively on antimicrobial therapy, creating a deep, specialized workflow that general apps cannot replicate. - Maintains a high update frequency of 7 releases in six months, reflecting a commitment to current clinical guidelines. - **[Merck Manual Professional](https://marlvel.ai/intel-report/medical/merck-manual-professional)** by Merck & Co Inc [Moat: Medium]: A trusted, authoritative brand that provides high-quality clinical content for medical professionals. - Leverages the prestigious Merck Manual brand to establish immediate clinical authority and trust with medical professionals. - Provides comprehensive, peer-reviewed medical content that serves as a primary reference for complex clinical decision-making. ### Peers (What They Do Better) - **[DynaMed](https://marlvel.ai/intel-report/medical/dynamed)** by EBSCO Publishing: A direct competitor in the clinical decision support space, focusing on evidence-based medicine. - Integrates evidence-based clinical summaries designed specifically for rapid point-of-care decision support in hospital settings. - Utilizes a robust editorial process that prioritizes the most current clinical evidence over general drug information. - **[Calculate by QxMD](https://marlvel.ai/intel-report/medical/calculate-by-qxmd)** by WebMD: Adjacent toolset focusing on clinical calculators rather than drug monographs. - Provides a vast library of clinical calculators that streamline complex medical scoring and risk assessment workflows. - Offers a highly interactive user experience that complements static drug reference apps like the target. - **[Figure 1 - Medical Cases](https://marlvel.ai/intel-report/medical/figure-1-medical-cases)** by Figure 1, Inc.: A social-professional network that provides clinical context through shared medical cases. - Facilitates peer-to-peer learning through a visual, case-based social network for healthcare professionals. - Drives high engagement through community-driven discussions on rare and complex clinical presentations. - **[Micromedex](https://marlvel.ai/intel-report/medical/micromedex)** by Merative: A legacy professional drug reference tool that competes directly for the clinical audience. - Provides deep, institutional-grade drug information that is often integrated into hospital-wide clinical systems. - Focuses on high-stakes clinical safety data, catering to the specific needs of pharmacists and hospital clinicians. ### New Kids on the Block (What's Innovative) - **[Pill Identifier by Drugs.com](https://marlvel.ai/intel-report/medical/com-drugs-pillidlite)** by Drugs.com: A focused, single-utility app that addresses a specific, high-frequency user pain point. ## What's New - **Latest (v9.4.2, 1 weeks ago):** General bug fixes. ## App Momentum (Maintenance) {#momentum} - Ships general bug fixes only. - Last major release Apr 2026. > **Cadence:** 5 total versions · 1 majors in last 6 months · 8 days since last update · 45 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} UpToDate Lexidrug is a challenged medical app that is available. With a 4.19/5 rating from 7.6K reviews, it faces significant user friction. > **Bottom Line:** UpToDate Lexidrug maintains a strong clinical moat through editorial rigor, but technical instability in the latest release is actively driving professional churn, so the team must prioritize stability over feature expansion to protect the subscription base. **Best for:** Healthcare professionals including pharmacists, physicians, nurses, and students requiring evidence-based drug information. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] [HIGH IMPACT] Rebuild database download logic because download failures are the #1 complaint → restore core clinical utility — *Database download failures are the top-cited complaint, directly preventing access to life-critical drug interaction data.* _(trade-off: deprioritize Pause the medical calculator UI refresh — stability is the primary churn driver.)_ - [ ] [PIVOT] [MEDIUM IMPACT] Restore drug library icon to home screen because UI navigation complaints are the #2 churn risk → improve daily workflow — *User feedback explicitly requests returning the drug database icon to the main landing page to reduce menu clicks.* _(trade-off: deprioritize Deprioritize the new onboarding tutorial — current users are the priority for retention.)_ ### Feature Gaps vs Competitors - Real-time pill identification (available in Drugs.com but missing here) - Social case-based learning (available in Figure 1 but missing here) ### Outlook: Declining The professional medical reference market is consolidating around tools that provide high-speed, reliable point-of-care access. UpToDate Lexidrug's current technical instability and UI friction leave it exposed to niche competitors, so the team must shift from feature-parity to stability-first engineering to prevent further subscription loss. - 🔴 Persistent database download failures prevent access to critical clinical data, which directly causes professional churn to more stable competitors. - 🔴 UI navigation changes hide essential tools behind excessive menus, slowing down point-of-care workflows and reducing daily active usage. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.19/5 | | Total Reviews | 7.6K | | Sentiment | Frustrated (25/100) | | Confidence | High | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 4 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **UpToDate Lexidrug** (this app) | 4.19/5 | Frustrated | Lexi-Comp | | [Pill Identifier by Drugs.com](https://marlvel.ai/intel-report/medical/com-drugs-pillidlite) | 3.4/5 | Frustrated | Drugs.com | | [Sanford Guide Antimicrobial](https://marlvel.ai/intel-report/medical/com-sanfordguide-amt) | 4.8/5 | N/A | Antimicrobial Therapy, Inc. | | [Drugs.com Medication Guide](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide) | 4.8/5 | Excited | Drugs.com | | [Merck Manual Professional](https://marlvel.ai/intel-report/medical/merck-manual-professional) | 4.8/5 | N/A | Merck & Co Inc | | [Calculate by QxMD](https://marlvel.ai/intel-report/medical/calculate-by-qxmd) | 4.8/5 | N/A | WebMD | ## Company Profile - **Developer:** Lexi-Comp - **Website:** [https://www.wolterskluwercdi.com](https://www.wolterskluwercdi.com) - **Social:** [Instagram](https://www.instagram.com/_wolterskluwer) · [Facebook](https://www.facebook.com/TeamMateAudit) · [YouTube](https://www.youtube.com/channel/UCxbSmCodEoCYCA1WDPSBeCQ) · [LinkedIn](https://www.linkedin.com/company/teammateaudit) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/uptodate-lexidrug/id313401238?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.lexi.android&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.wolterskluwercdi.com) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*Pill Identifier by Drugs.com*](https://marlvel.ai/intel-report/medical/com-drugs-pillidlite) (Drugs.com) — 3.4/5 Rating | Negative Sentiment - [*Sanford Guide Antimicrobial*](https://marlvel.ai/intel-report/medical/com-sanfordguide-amt) (Antimicrobial Therapy, Inc.) — 4.8/5 Rating | N/A Sentiment - [*Drugs.com Medication Guide*](https://marlvel.ai/intel-report/medical/drugs-com-medication-guide) (Drugs.com) — 4.8/5 Rating | Positive Sentiment - [*Merck Manual Professional*](https://marlvel.ai/intel-report/medical/merck-manual-professional) (Merck & Co Inc) — 4.8/5 Rating | N/A Sentiment - [*Calculate by QxMD*](https://marlvel.ai/intel-report/medical/calculate-by-qxmd) (WebMD) — 4.8/5 Rating | N/A Sentiment - [*Figure 1 - Medical Cases*](https://marlvel.ai/intel-report/medical/figure-1-medical-cases) (Figure 1, Inc.) — 4.7/5 Rating | N/A Sentiment - [*DynaMed*](https://marlvel.ai/intel-report/medical/dynamed) (EBSCO Publishing) — 4.9/5 Rating | N/A Sentiment - [*Micromedex*](https://marlvel.ai/intel-report/medical/micromedex) (Merative) — 3.8/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.9/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 106 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-lexi-individual) Data licensed for AI Agent attribution under CC-BY-NC 4.0.